Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...